MedTrace Logo

Pulse Wave Velocity Imaging in the Assessment of PAD

NCT03516383 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2018-05-04

No results posted yet for this study

Summary

The purpose of this study is to predict the outcome of peripheral revascularization surgery by use of a new technology developed by our team, Pulse Wave Velocity imaging (PWVI), which has the capability to detect pulse transit time (PTT), and pulse wave velocity (PWV). This PWVI will be compared against known gold standards pre and post lower extremity limb revascularization and used to evaluate outcomes. Specifically, is leg PWV different among those with or without PAD, and is leg PWV different among those who undergo revascularization surgery and those who do not? This study represents the first clinical pilot study of the device with the aim to expand study participant numbers in future research and to eventually develop a PAD screening tool. This would be the first of its kind ever described.

Conditions

  • PAD
  • Optical Imaging

Interventions

DEVICE

PWVi

Sponsors & Collaborators

  • Toronto Metropolitan University

    collaborator OTHER

  • Unity Health Toronto

    lead OTHER

Principal Investigators

  • Karen Cross, MD, PhD · Unity Health Toronto

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2017-06-30
Completion
2017-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03516383 on ClinicalTrials.gov